COLLIER ALAN BRIAN (CEO) purchased 0.0% of their position (10.40K shares) of ENDONOVO THERAPEUTICS, INC. on the open market
Open‑market purchase worth $106.96 — a small addition. The strongest form of insider conviction signal.
Common Stock
Shares
+1K
Price / share
$0.01
Trade value
$9.90
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$19.80
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$20.80
% of position
Common Stock
Shares
+1K
Price / share
$0.01
Trade value
$10.30
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$21.00
% of position
Common Stock
Shares
+200.00
Price / share
$0.01
Trade value
$2.00
% of position
Common Stock
Shares
+2K
Price / share
$0.01
Trade value
$21.00
% of position
Common Stock
Shares
+200.00
Price / share
$0.01
Trade value
$2.16
% of position
Net shares
+10.40K
Net value
$106.96
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/2/2019 | P · Purchase | +1K | $0.01 | $9.90 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 10/2/2019 | P · Purchase | +2K | $0.01 | $19.80 | 0.0% | 25.33M | 25.33M |
| Common Stock Direct | 10/3/2019 | P · Purchase | +2K | $0.01 | $20.80 | 0.0% | 25.33M | 25.34M |
| Common Stock Direct | 10/3/2019 | P · Purchase | +1K | $0.01 | $10.30 | 0.0% | 25.34M | 25.34M |
| Common Stock Direct | 10/4/2019 | P · Purchase | +2K | $0.01 | $21.00 | 0.0% | 25.34M | 25.34M |
| Common Stock Direct | 10/7/2019 | P · Purchase | +200.00 | $0.01 | $2.00 | 0.0% | 25.34M | 25.34M |
| Common Stock Direct | 10/15/2019 | P · Purchase | +2K | $0.01 | $21.00 | 0.0% | 25.34M | 25.34M |
| Common Stock Direct | 10/15/2019 | P · Purchase | +200.00 | $0.01 | $2.16 | 0.0% | 25.34M | 25.34M |
| Total | +10.40K | $106.96 | ||||||